Diversität in klinischen Studien – unser aktiver Dialog mit Pharmaunternehmen
Um die Qualität und Sicherheit von Arzneimitteln für verschiedene Bevölkerungsgruppen zu testen, ist eine große Vielfalt der Teilnehmer an klinischen Studien von hoher Bedeutung.
CO2-Abscheidung und-Speicherung: Chancen auf einem boomenden Markt
CO2-Abscheidung und -Speicherung (CCS) kann einen entscheidenden Beitrag dazu leisten, dass die Welt ihre ehrgeizigen Netto-Null-Emissionsziele erreicht.
ESG Viewpoint: The cost of gender disparity in Asian companies
We’ve been engaging with 26 of Asia’s most influential companies on this topic.
Investment conclusions from 2023’s clean energy sell-off
The clean energy index had a tough 2023, but we believe there was an overreaction in markets that didn’t appreciate the nuance of the energy transition.
ESG Viewpoint: Investing in a Just Transition
It’s essential we consider the social dimension as we transition to a low carbon world. We explore the investment implications of a Just Transition.
Carbon capture and storage: opportunities in a burgeoning market
CCS has the potential to play a major role in delivering ambitious emission-reduction targets. We run the rule over the marketplace
ESG Viewpoint: Interpreting climate data for investment portfolios
Climate change and the energy transition will impact the long-term performance of investment portfolios. Here we look at how investors should interpret climate data for managing investment portfolios.
ESG Viewpoint: Diversity in clinical trials
Despite a clear scientific and commercial imperative, a significant gap between patient and trial populations persists. We explain why diversity in clinical trials matters to investors and explore our engagement with companies.
COP28 – main takeaways and key outcomes
A last-minute deal on transitioning away from fossil fuels was agreed – but will commitments be implemented? We assess this and other progress made at the 28th round of climate change negotiations in Dubai.
Global Sustainable Outcomes Q3 2023
As interest rates rise, global financial and economic risks also rise, with the renewable sector experiencing a ‚black swan‘ event in 2023.